Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “cannabidiol” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 17
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 17 pipeline programs matching "cannabidiol" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

17 results for “cannabidiol” Back to intelligence hub

Search results

  1. CARDIOL 100-03

    Cardiol Therapeutics

    COVID-19

    phase 3 small molecule terminated

    1 trial
  2. Cannabidiol

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder (OUD)

    phase 3 small molecule active

    1 trial
  3. Cannabidiol (CBD)

    Jazz Pharmaceuticals Ireland Limited

    Clinical High Risk for Psychosis (CHR)

    phase 3 small molecule active

    1 trial
  4. Cannabidiol Oil

    Hospital Authority, Hong Kong

    Dementia, Vascular

    phase 3 small molecule active

    1 trial
  5. ZYN002 Transdermal Gel Cannabidiol (CBD)

    Harmony Biosciences Holdings

    Fragile X Syndrome (FXS)

    phase 3 small molecule active

    1 trial
  6. CANNABIDIOL, DRONABINOL

    Disc Medicine

    Patients with untreatable hepatocellulare carcinoma

    phase 2 small molecule active

    1 trial
  7. Cannabidiol

    Jazz Pharmaceuticals Ireland Limited

    Sturge-Weber Syndrome

    phase 2 small molecule completed

    2 trials
  8. Cannabidiol

    Jazz Pharmaceuticals Ireland Limited

    Early Life Adversity

    phase 2 small molecule active

    1 trial
  9. Cannabidiol

    BRIGHT MINDS BIOSCIENCES INC.

    Radiculopathy

    phase 2 small molecule completed

    1 trial
  10. Cannabidiol (CBD) 600 mg

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 2 small molecule completed

    1 trial
  11. Cannabidiol - fsCBD

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use Disorder

    phase 2 small molecule active

    1 trial
  12. Softisan 378, Cannabidiol

    Disc Medicine

    psychological disorders: PTSD; Anxiety disorders

    phase 2 small molecule active

    1 trial
  13. 400 mg Cannabidiol

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 1 small molecule active

    1 trial
  14. Cannabidiol, Medium Dose

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis

    phase 1 small molecule active

    1 trial
  15. Cannabidiol

    Jazz Pharmaceuticals Ireland Limited

    Lennox Gastaut Syndrome

    approved small molecule active

    1 trial
  16. Cannabidiol (Epidiolex)

    Jazz Pharmaceuticals Ireland Limited

    Study the Efficacy of Epidiolex for Typical Absence Seizures

    approved small molecule completed

    1 trial
  17. Cannabidiol Oral Solution [Epidiolex]

    Jazz Pharmaceuticals Ireland Limited

    Tuberous Sclerosis Complex Associated Neuropsychiatric Disease

    approved small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.